Clinical trials: Swallowing
Dysphagia, Dysphagia, Oral Phase
Dose-response Effect of the Thickener Tsururinko Quickly
Thickening fluids are a valid therapeutic strategy to improve safe swallowing in OD. The aim of this study is to assess the percentage of safe swallowing at different viscosity levels thickened with Tsururinko Quickly.
- Conditions
- Dysphagia, Dysphagia, Oral Phase, Dysphagia, Oropharyngeal, Dysphagia, Esophageal
- Trial name
- 58/19 (NCT04565587)
- Testing
- Xanthan-gum based thickener
- Where
- Spain
- Volunteers
- 120 people
- Sponsor
- Morinaga Milk Industry Co., LTD
Swallowing Disorders
NewBreez Safety and Efficacy Evaluation
The objective of this clinical study is to evaluate the safety and efficacy of the NewBreez intra-laryngeal implant in patients with dysfunctional larynx.
- Trial name
- NCT01587664
- Testing
- NewBreez ILP
- Where
- 2 sites in Belgium, France
- Volunteers
- 2 people
- Sponsor
- ProTiP Medical
Predictable BTP at Swallowing in in Head/Neck Cancer Patients Undergoing Radiotherapy Already Receiving Opioid Therapy for Background Pain
PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy
The primary objective of the present phase IIIb study is to assess the efficacy of FPNS compared with Physician Choice-Usual Care (PC-UC) in the reduction of swallowing predictable BTP in head and neck cancer patients undergoing…
- Trial name
- PERFECT FAST (NCT01980498)
- Testing
- Fentanyl pectin nasal spray (FPNS), Physician choice-Usual care (PC-UC)
- Where
- 25 sites in Italy
- Sponsor
- L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.